Skip to content

Menu

LexBlog, Inc. logo
CommunitySub-MenuPublishersChannelsProductsSub-MenuBlog ProBlog PlusBlog PremierMicrositeSyndication PortalsAboutContactResourcesSubscribeSupport
Join
Search
Close

New government incentives for private and foreign investment

By Wang Jing (CN) & Lynn Yang (CN) on December 22, 2014
Email this postTweet this postLike this postShare this post on LinkedIn

The Chinese government recently announced guidelines for the easing of market access barriers in a number of industries. The medical and healthcare industry has been identified as one of these key sectors.

The new regulations aim to encourage more private and foreign investment to further develop the country’s healthcare infrastructure.

Starting 1 January 2015, the government will introduce new financial incentives for foreign investment in senior care businesses.

We anticipate that 2015 will likely to attract more active private and foreign investment and M&A activities, in particular in the senior care sector.

International healthcare providers and private equity firms interested in the Chinese healthcare market should take note of these developments.

Please click below to view our full briefings for further information.

  • Easing of market access barriers to encourage private investment
  • Government incentives for foreign investors in for-profit senior care
Photo of Wang Jing (CN) Wang Jing (CN)

Wang Jing is a corporate lawyer based in Beijing. He has broad experience of advising on cross-border transactions including mergers and acquisitions, joint ventures, inbound and outbound investment, reorganisations, and corporate and commercial matters.

In cross-border transactions, Jing has been involved in all…

Wang Jing is a corporate lawyer based in Beijing. He has broad experience of advising on cross-border transactions including mergers and acquisitions, joint ventures, inbound and outbound investment, reorganisations, and corporate and commercial matters.

In cross-border transactions, Jing has been involved in all stages of cross-border transactions, including due diligence, regulatory advice, structuring, documentation, negotiation and closing. His experience covers a wide array of sectors with a focus on pharmaceutical and biosciences.

Jing obtained an LL.B. and LL.M. from both Peking University Law School in 1997 and 2000, respectively. He received another LL.M. from the School of Law of the University of Washington. He is admitted to the New York State Bar and the Chinese Bar. Jing is a native Chinese speaker and is fluent in English.

Read more about Wang Jing (CN)Email
Show more Show less
Photo of Lynn Yang (CN) Lynn Yang (CN)

With over 16 years’ experience, Lynn has broad experience in advising on cross-border mergers & acquisitions, public takeovers, joint ventures, private equity investment, pre-IPO restructuring, foreign direct investment, reorganization of investment portfolios, general corporate matters in China in a wide range of sectors.

Read more about Lynn Yang (CN)Email
  • Posted in:
    Health Care
  • Blog:
    Health Law Pulse
  • Organization:
    Norton Rose Fulbright
  • Article: View Original Source

LexBlog, Inc. logo
Facebook LinkedIn Twitter RSS
Real Lawyers
99 Park Row
  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service
  • Products
  • Blog Pro
  • Blog Plus
  • Blog Premier
  • Microsite
  • Syndication Portals
  • LexBlog Community
  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center

New to the Network

  • Boston ERISA & Insurance Litigation Blog
  • Stridon News and Insights
  • Taft Class Action & Consumer Insights
  • Labor and Employment Law Insights
  • Age of Disruption
Copyright © 2022, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo